As these patients exhibit unexpectedly higher levels of PLA2R antibody titers and poorer prognoses than their double-positive counterparts 65, 67, the absence of PLA2R in this group may result from a failure to accumulate ICs in the GBM. The gene discussed is PLA2R1; the disease is glioblastoma.